1. Introduction {#sec1}
===============

Regular exercise can lower systemic inflammation in both healthy and clinical populations ([@bib21], [@bib22]). The cumulative impact of acute inflammatory responses that follow individual exercise bouts is believed to be a major stimulus for creating this anti-inflammatory environment, which appears more marked at higher exercise intensities ([@bib37]). The mechanisms underpinning these effects are primarily attributed to: 1) increased release of myokines from skeletal muscle (e.g. IL-6), 2) phenotypic shifts in cell composition (blood monocytes and adipose tissue-resident macrophages) and 3) a reduction in the expression of membrane-bound immune receptors that govern immune cell activity, migration and inflammatory cytokine production ([@bib16]). The independent contribution of these factors is far from clear and a myriad of other mechanisms likely contribute. For example, programmed-death receptor-1 (PD-1) is an immune checkpoint receptor with an established role in regulating circulating inflammatory signals ([@bib9]) but is yet to be extensively characterised following acute exercise or periods of exercise training.

PD-1 is a membrane-bound receptor primarily expressed on lymphoid cells that provides a 'brake' or checkpoint for the immune system ([@bib15]). PD-1 interacts specifically with its co-stimulatory ligands, PD-Ligand 1 (PD-L1) and 2 (PD-L2), which are ubiquitously expressed. These ligand-receptor interactions result in reduced immune cell activity and thus provide an anti-inflammatory environment that is critical for the maintenance of immunological homeostasis. It is now well established that aberrant expression of PD-1 can dramatically affect immune function and health ([@bib2]; [@bib18]; [@bib25]; [@bib26]; [@bib29]; [@bib31]; [@bib33]). High expression of PD-1 on certain immune cells (e.g. cytotoxic T-cells (CD8^+^)) is known to severely suppress immune function in numerous blood and tissue cancers ([@bib26]; [@bib31]; [@bib33]). Conversely, reduced expression of PD-1 has been documented on CD8^+^ T-cells from patients with autoimmune diseases, such as type-1 diabetes ([@bib18]; [@bib25]), rheumatoid arthritis ([@bib29]) and Psoriasis ([@bib2]), driving autoimmunity. These studies underpin the central role that PD-1 has in regulating immunological homeostasis, and yet, alterations in PD-1 expression have only recently been explored for the first time in the context of exercise ([@bib20]).

[@bib20] reported that a single session of maximal cycling marginally increased the blood composition of PD-1+ T-cells within CD4^+^ (+3.15%) and CD8^+^ (+5.53%) subsets ([@bib20]). It is well documented that the influx of lymphocytes into the circulation during exercise is largely driven by CD8^+^, rather than CD4^+^ T-cells ([@bib35]), and is dependent on the intensity of the bout ([@bib4]). The composition of this CD8^+^ T-cell pool is markedly altered to favour increased immune surveillance for antigen-presentation at secondary lymphoid organs and inflamed tissues ([@bib10]). PD-1 is primarily expressed on memory cells ([@bib7]) and functions to limit the inflammatory response by increasing apoptosis of antigen-specific effector T-cells ([@bib15]); however, how antigen-specific frequencies of CD8^+^ T-cells expressing PD-1 change following exercise bouts of different intensities is currently unknown. Further to the membrane-bound forms of PD-1 and PD-L1, soluble (s) PD-1 and sPD-L1 are detectable within the extracellular environment of blood ([@bib6]; [@bib38]), but have yet to be explored in the context of exercise, despite their role in modulating T-cell activity ([@bib28]; [@bib34]).

Our collective understanding of both membrane and soluble PD-1 in the context of exercise and immunity is currently lacking, particularly regarding how exercise alters the specific memory phenotype of T-cells expressing PD-1, their physiological relevance in blood (i.e. number of cells expressing PD-1) and relationships to sPD-1 and sPD-L1. Characterisation of these responses could provide important insight into the anti-inflammatory effects that underpin exercise, with important subsequent implications for health and immunity. The aim of the present study was to characterise changes in the expression of PD-1 in circulating naïve, central memory, effector memory and terminally differentiated CD8^+^ T-cells following two time and energy-matched bouts of moderate and high intensity cycling. To better understand the link between cellular PD-1 and plasma sPD-1/sPD-L1 in the context of inflammation, sample-matched IL-6 measurements were made.

2. Materials and methods {#sec2}
========================

2.1. Participants {#sec2.1}
-----------------

Following ethical approval from the University of Worcester Research Ethics Committee, eight healthy males (mean ​± ​SD: age 29 ​± ​5 years; BMI 24.2 ​± ​3.4 ​kg ​m^2^; $\overset{˙}{V}$O~2max~ 44.5 ​± ​6.4 ​ml ​kg^−1^·min^−1^) were recruited to take part in the study. All participants completed questionnaires addressing health history and habitual levels of weekly physical activity using the International Physical Activity Questionnaire (IPAQ). All participants gave their written informed consent and the study was carried out in accordance with the Declaration of Helsinki (2008). Participants were non-smokers and reported that they had not taken any antioxidant vitamin supplements or anti-inflammatory drugs for 8 weeks prior to the laboratory visit. In addition, participants reported to be free from any viral or bacterial infections for at least 4 weeks prior to taking part. Participants were also required to refrain from any strenuous physical activity, consumption of alcoholic beverages or caffeine for two days prior to each experimental session.

2.2. Experimental sessions {#sec2.2}
--------------------------

Participants reported to the laboratory on three separate occasions, all carried out under stable climatic conditions (18--20 ​°C and humidity between 45 -- 55%). Following a 30-min period of rest, resting heart rate (*RS400, Polar Electro, Finland*), height (*Seca Alpha, Hamburg, Germany*) and body mass *(Tanita, Tokyo, Japan)* were determined on each visit. On participants first visit, cardiorespiratory fitness ($\overset{˙}{V}O_{2}$~max~) was assessed using a ramp test to exhaustion on an electromagnetically braked cycle ergometer (*Lode Excalibur Sport*, *Groningen*, *Netherlands*). Workload commenced at 100 Watts and was increased by 30 Watts every 4 ​min. Heart rate and oxygen uptake was assessed continuously using a breath-by-breath system (Cortex Biophysik Metalyzer, Germany). $\overset{˙}{V}O_{2}$~max~ was determined if two of the following criteria were met in conjunction with a plateau in oxygen consumption after an increase in workload: volitional exhaustion; a respiratory exchange ratio of ≥1.15; heart rate within 10 beats·min^−1^ of the age-predicted maximal heart rate (220 - age); a drop in cadence below 60 ​revolutions per minute ([@bib24]). A final obtained value of rate of oxygen consumption relative to body mass was accepted as $\overset{˙}{V}O_{2}$~max~ (ml.kg^−1^min^−1^) and used to inform the workload for the subsequent two trials.

At least one week following the $\overset{˙}{V}O_{2}$~max~ test, participants undertook two energy and time-matched cycling trials in a counterbalanced order: a moderate intensity bout of continuous cycling at 60% $\overset{˙}{V}O_{2}$~max~ for 58 ​min (MOD) and a bout of high intensity interval exercise (HIIE), consisting of 10 x 4-min intervals at 85% $\overset{˙}{V}O_{2}$~max~, with 2-min rest intervals. Both trials took place following an identical overnight fast at least one week apart. In both studies, oxygen uptake was assessed continuously to maintain target $\overset{˙}{V}O_{2}$ and ensure equal energy expenditure between MOD and HIIE. Ratings of perceived exertion (RPE) were measured every 6 ​min during the trials.

2.3. Blood sampling {#sec2.3}
-------------------

In both MOD and HIIE, a catheter (*Appleton Woods, Birmingham, UK)* was inserted into the antecubital vein of the arm prior to exercise to obtain a baseline sample after 30 ​min of rest (Pre-Ex). Additional blood samples were taken immediately (Post-Ex), 30 ​min (Post-Ex+30) and 60 ​min (Post-Ex+60) following completion of each cycling trial. At Pre and Post+0 timepoints, 18 ​ml of blood was drawn into two separate vacutainer tubes containing potassium ethylene diaminetetraacetic acid (EDTA) (*Becton, Dickson & Company, Oxford, UK*) for independent isolation or peripheral blood monocular cells (PBMCs) and plasma. At Post-Ex+30 and Post-Ex+60 timepoints, 9 ​ml of blood was collected for plasma isolation only. The catheter was flushed every 30 ​min with isotonic saline solution (0.9% sodium chloride) to prevent blood clotting.

2.4. Plasma analyses {#sec2.4}
--------------------

A cytometric bead array technique was used to quantify plasma interleukin (IL)-6 on a BD C6 Accuri Flow Cytometer (*BD Biosciences*, Berkshire). Plasma PD-L1 (BMS2212; sensitivity: 0.6 ​pg/ml, intraassay CV: 2.1%, interassay CV: 3.4%) and PD-1 (BMS2214; sensitivity 1.14 ​pg/ml, intraassay CV: 3.2%, interassay CV: 6.4%) were quantified using commercially available ELISA kits (*Thermo Fisher Scientific*, Loughborough). All concentrations were corrected for changes in plasma volume based upon established criteria ([@bib12]).

2.5. Isolation of CD8^+^ T-cells {#sec2.5}
--------------------------------

Whole blood from Pre-Ex and Post-Ex timepoints only were used to isolate PBMCs using density gradient centrifugation. Blood was diluted 1:1 with Hanks Balance Salt Solution (HBSS), and then layered carefully on top of Histopaque 1077 (*Sigma, Dorset*), before centrifuging at 400*g* for 40 ​min at 21 ​°C. The PBMC layer was aspirated and then washed three times with HBSS, by centrifuging steps at 300*g* for 10 ​min. Approximately 3 million cells per time point were then used to enrich CD8^+^ T-cells by negative selection using MACS® bead separation (*Miltenyi Biotec, Surrey, UK*). PBMCs were incubated with a biotin-antibody cocktail (anti-CD4, CD15, CD16, CD19, CD34, CD36, CD56, CD123, TCRγ/δ, and CD235a), followed by a CD8^+^ T-cell microbead cocktail (anti-CD14, CD61 and anti-biotin) for 10 ​min at 4 ​°C, with intermittent washes using column wash buffer (PBS supplemented with 0.5% bovine serum albumin and 2 ​mM EDTA; pH ​= ​7.2). CD8^+^ cells from both time-points were eluted by negative selection using three separate MiniMACS LD-column passes, using an excess of de-gassed column buffer (*Miltenyi Biotec, Surrey, UK*). CD8^+^ T-cell enrichment was confirmed by flow cytometry staining analysing the CD3^+^CD8^+^ lymphocyte population (\>95% purity).

2.6. Flow cytometry {#sec2.6}
-------------------

Approximately 1,000,000 viable PBMCs were used for determination of CD8^+^ T-cell subsets and expression of PD-1 using four-colour flow cytometry (*Guava EasyCyte*, *Millipore UK Ltd, Hertfordshire, UK*). Cells were incubated with fluorescently conjugated antibodies -- CD3-FITC (clone: HIT3a), CD279-PE (clone: EH12.2H7), CD45RA-PerCP (clone: HI100), CD27-APC (clone: M-T271) (*Biolegend*, *Cambridge, UK*) for 30 ​min at 4 ​°C followed by intermittent washes with PBS for 5 ​min at 300×*g*. Compensation was adjusted daily by using single stained controls and gates established using fluorescence minus one controls. Confirmation of non-specific antibody binding was determined by using isotope-matched controls.

Flow cytometry data were analysed using GuavaSoft 3.1 (*Millipore UK Ltd, Hertfordshire, UK*). Briefly, lymphocytes were gated on forward versus side scatter and CD3^+^ and CD8^+^ T-cell proportions used to determine MACS enrichment efficacy. MACS enriched CD8^+^ T-cells were identified as naïve (CD27^+^ CD45RA+), central memory (CD27^+^ CD45RA-), effector memory (CD27^−^ CD45RA-), or terminally differentiated effector memory cells (T~EMRA~: CD27^−^ CD45RA+) accordingly ([@bib11]). Within each sub-population, mean fluorescence intensity (MFI) and percentage positive cells was established for PD-1 (CD279). The percentage of PD-1+ cells were used with whole blood cell counts to determine the circulating number of PD-1+ cells in peripheral blood for each sub-population, and adjusted for changes in plasma volume.

2.7. Statistical analysis {#sec2.7}
-------------------------

The Shapiro Wilk test was used to check for normality in scale data at all time points. Variables with a non-normal distribution were log transformed if necessary. Changes in sub-populations of immune cells, CD8^+^ cells expressing PD-1, PD-1 expression levels and plasma markers (sPD-1, sPD-L1 and IL-6) were assessed over time (Pre, Post, Post-Ex+30 and Post-Ex+60) and between Trials (MOD, HIIE) by a 2∗2 (cellular data) or 2∗4 (plasma data) repeated-measures analysis of variance (ANOVA) or Wilcoxon Signed Rank Tests, depending on variable normality. Post hoc analysis of any ANOVA interaction effects (Trial∗Time) were performed by a test of simple effects by pairwise comparisons, with Bonferroni correction. Mann Whitney U tests were performed to determine differences between MOD and HIIE at different timepoints for non-parametric data. Effect sizes for main effects and interaction effects of ANOVA are presented as partial eta^2^ (η^2^~p~), using Cohen's definition of η^2^~p~ of 0.01, 0.06 and 0.14 for 'small', 'medium' and 'large' effects respectively ([@bib8]). Pearson correlation and Spearman rank were used to assess the relationship between parametric and non-parametric data respectively. All values are presented as means ​± ​standard deviation or error (indicated throughout manuscript). Data were back transformed for ease of presentation in figures. Statistical significance was accepted at the P ​\< ​0.05 level. Statistical analyses were performed using SPSS (*PASW Statistics, release 23.0, SPSS Inc., Chicago, IL, USA*).

3. Results {#sec3}
==========

3.1. Physiological response during MOD and HIIE {#sec3.1}
-----------------------------------------------

The physiological responses during each exercise bout are reported in detail elsewhere ([@bib36]). Briefly, Peak $\overset{˙}{V}O_{2}$ and RPE were significantly greater in HIIE compared to MOD (P ​\< ​0.00001), but there were no statistically significant differences in mean $\overset{˙}{V}O_{2}$ and energy expenditure.

3.2. Changes in lymphocyte sub-populations after MOD and HIIE in blood {#sec3.2}
----------------------------------------------------------------------

Changes in lymphocyte and CD8^+^ T-cell subset concentrations are reported in [Table 1](#tbl1){ref-type="table"}, [Table 2](#tbl2){ref-type="table"} respectively. Total lymphocyte concentration increased after both trials (P ​= ​0.014). Within the lymphocyte pools, CD3^+^ (P ​= ​0.011) and CD8^+^ (P ​= ​0.006) T-cell concentrations also increased, with no differences between MOD and HIIE for any lymphocyte subset. Within the CD8^+^ T-cell pool, naïve (P ​= ​0.050), central memory (P ​= ​0.036), effector memory (P ​= ​0.050) and T~EMRA~ (P ​= ​0.012) all increased following MOD, but only T~EMRA~ increased following HIIE (P ​= ​0.049). There were no statistically significant differences in CD8^+^ T-cell concentrations between MOD and HIIE at any timepoint.Table 1Mean changes (SD) in total lymphocytes, CD3^+^ and CD8^+^ T-cells before and after MOD and HIIE.Table 1Pre-ExercisePost-ExerciseMain Effects of TimeTime ​× ​Trial Interaction**Lymphocytes (cells/uL)***MOD1720.2 (651.1)2761.3 (1292.3) ∗F*~(1,7)~ ​= ​10.7; P ​= ​*0.014;* η^2^ ​= ​0.6*F*~(1,7)~ ​= ​0.03; P *= NSHIIE1559.4 (456.9)2523.7 (1165.7) ∗***CD3**^**+**^**T-cells (cells/uL)***MOD1272.8 (515.1)2022.19 (515.1) ∗F*~(1,7)~ ​= ​11.7; P ​= ​*0.011;* η^2^ ​= ​0.6*F*~(1,7)~ ​= ​0.02; P *= NSHIIE1180.9 (365.9)1877.2 (870.9) ∗***CD8**^**+**^**T-cells (cells/uL)***MOD419.5 (161.2)717.8 (337.4) ∗F*~(1,7)~ ​= ​15.1; P ​= ​*0.006;* η^2^ ​= ​0.7*F*~(1,7)~ ​= ​0.22; P *= NSHIIE413.0 (101.7)688.9 (310.6) ∗*[^1]Table 2Mean changes (SD) in CD8^+^ T-cell subsets before and after MOD and HIIE.Table 2Naïve CD8^+^ T-cells (cells/uL)Pre-ExPost-Ex*Time: Pre vs. Post***MOD**84.8 (120.3)161.7 (209.8) ∗*Z ​= ​-1.96; P ​= ​0.05,* η^2^ ​= ​0.24**HIIE**81.0 (63.1)116.8 (82.8)*Z ​= ​-1.12; P = NS**Trial: MOD vs HIIE**Z ​= ​-0.42; P = NSZ ​= ​0; P = NS***Central Memory CD8**^**+**^**T-cells (cells/uL)Pre-ExPost-Ex***Time: Pre vs. Post***MOD**50.3 (46.2)126.0 (142.1) ∗*Z ​= ​-2.10; P ​= ​0.036,* η^2^ ​= ​0.28**HIIE**89.9 (75.8)159.8 (158.6)*Z ​= ​-1.26; P = NS**Trial: MOD vs HIIE**Z ​= ​-1.05; P = NSZ ​= ​-0.84; P = NS***Effector Memory CD8**^**+**^**T-cells (cells/uL)Pre-ExPost-Ex***Time: Pre vs. Post***MOD**113.1 (72.5)166.9 (59.0) ∗*Z ​= ​-1.96 ​P ​= ​0.05,* η^2^ ​= ​0.24**HIIE**123.6 (96.1)168.0 (127.0)*Z ​= ​-1.12; P = NS**Trial: MOD vs HIIE**Z ​= ​0; P = NSZ ​= ​-0.63; P = NS***Terminally Differentiated Effector Memory CD8**^**+**^**T-cells (cells/uL)Pre-ExPost-Ex***Time: Pre vs. Post***MOD**171.3 (65.4)263.2 (94.1) ∗*Z ​= ​-2.52; P ​= ​0.012,* η^2^ ​= ​0.40**HIIE**118.4 (98.1)244.3 (184.5) ∗*Z ​= ​-1.82; P ​= ​0.049,* η^2^ ​= ​0.21***Trial: MOD vs HIIE**Z ​= ​-1.26; P = NSZ ​= ​-0.84; P = NS*[^2]

3.3. Changes in PD-1+ cell concentration, expression and composition within the CD8^+^ T-cell pool after MOD and HIIE {#sec3.3}
---------------------------------------------------------------------------------------------------------------------

PD-1 expression was significantly higher on central and effector memory T-cell subsets when compared to naïve or T~EMRA~ (P's ​\< ​0.0001). The circulating concentration of CD8^+^ PD-1+ T-cells was significantly higher after both trials (MOD: Z ​= ​−2.38, P ​= ​0.017, η^2^ ​= ​0.35 and HIIE: Z ​= ​−1.26, P ​= ​0.234), however there were no significant differences between trials (Z ​= ​−2.10, P ​= ​0.035, η^2^ ​= ​0.28). Changes in PD-1+ cell concentration and expression within CD8^+^ T-cell subsets are reported in [Fig. 1](#fig1){ref-type="fig"}, [Fig. 2](#fig2){ref-type="fig"} respectively. Within the CD8^+^ T-cell pool, there was a significant increase in PD-1+ central memory cells following HIIE only (Z ​= ​−2.31, P ​= ​0.021, η^2^ ​= ​0.33), with cell number significantly higher than MOD Post-Ex (Z ​= ​−2.52, P ​= ​0.010. η^2^ ​= ​0.40). In addition, PD-1 MFI was significantly greater in central memory cells following HIIE, indicating an increase in receptor expression (Z ​= ​−2.24, P ​= ​0.025, η^2^ ​= ​0.31).Fig. 1Changes in the concentrations of CD8^+^ T-cell subsets (naïve, central memory, effector memory and terminally differentiated effector memory (T~EMRA~) cells) before (black bars) and after (white bars) MOD (panel A) and HIIE (panel B). Values are means ​± ​standard error. ∗ indicates significant differences relative to Pre-Ex: ∗p ​\< ​0.05.+indicates a significant difference between MOD and HIIE:+p ​\< ​0.05.Fig. 1Fig. 2Changes in the expression of PD-1 in CD8^+^ T-cells and their subsets before (black bars) and after (white bars) MOD (panel A) and HIIE (panel B). Values are means ​± ​standard error. ∗ indicates a significant difference relative to Pre-Ex: ∗p ​\< ​0.05. \# indicates significantly higher expression levels in memory T-cells subsets, compared to naïve and T~EMRA~: \#\#\#p ​\< ​0.0001.Fig. 2

3.4. Changes in sPD-1, sPD-L1 and IL-6 in response to MOD and HIIE and associations with cellular variables {#sec3.4}
-----------------------------------------------------------------------------------------------------------

Changes in plasma levels of sPD-1 and sPD-L1 are reported in [Fig. 3](#fig3){ref-type="fig"} sPD-L1 concentration increased immediately (MOD: Z ​= ​−2.38, P ​= ​0.017, η^2^ ​= ​0.35 and HIIE: Z ​= ​−2.38, P ​= ​0.017, η^2^ ​= ​0.35) after exercise and was elevated Post-Ex+30 and Post-Ex+60 (MOD: Z ​= ​−2.52, P ​= ​0.012, η^2^ ​= ​0.40 and HIIE: Z ​= ​−2.52, P ​= ​0.012, η^2^ ​= ​0.40). A decrease in sPD-1 concentration was observed immediately after both trials (MOD: Z ​= ​−2.52, P ​= ​0.012, η^2^ ​= ​0.40 and HIIE: Z ​= ​−2.24, P ​= ​0.025, η^2^ ​= ​0.31), and remained below Pre-Ex levels at Post-Ex+60 (MOD: Z ​= ​−2.38, P ​= ​0.017, η^2^ ​= ​0.35 and HIIE: Z ​= ​−2.10, P ​= ​0.036, η^2^ ​= ​0.28). IL-6 concentration increased above Pre-Ex at all post-exercise timepoints in both trials (Time effect: F (3) ​= ​15.5, P ​\< ​0.0001, η^2^ ​= ​0.66), with the magnitude of increase significantly greater following HIIE (Time x Condition effect: F (3) ​= ​7.0, P ​\< ​0.001, η^2^ ​= ​0.47). A positive correlation was noted between concentrations of IL-6 and PD-L1 Post-Ex (r ​= ​0.57; P ​= ​0.021). No statistically significant correlations were noted between plasma and cellular variables.Fig. 3Changes in the concentrations of PD-L1 (A) and PD-1 (B) before (Pre-Ex) and after (Post-Ex, Post-Ex+30 and Post-Ex+60) MOD (grey bars) and HIIE (white bars). Values are means ​± ​standard error. ∗ indicates a significant difference relative to Pre-Ex: ∗p ​\< ​0.05. \# indicates a significant difference relative to Post-Ex: \#p ​\< ​0.05.Fig. 3

4. Discussion {#sec4}
=============

The current study highlights that single bouts of moderate and high intensity interval exercise evoke an increase in the circulating concentration of PD-1+ CD8^+^ T-cells in young, untrained, healthy males. As part of this response, the number of PD-1+ CD8^+^ central memory T-cells increased following HIIE only, with PD-1 expression also increased on these cells. Plasma sPD-L1 and sPD-1 increased and decreased respectively after both trials, with a positive association noted between IL-6 and PD-L1. Taken together, these results highlight a phenotypic specific change in the regulation of PD-1 on CD8^+^ T-cells that is exercise intensity-dependent. Furthermore, we highlight for the first time that soluble forms of the PD-1 receptor and ligand are reciprocally regulated after exercise, and relate to changes in IL-6. This study provides evidence of a potentially novel aspect of the anti-inflammatory response to exercise and warrants further investigation to contextualise the findings amongst other established mechanisms.

A single session of exercise induces large haemodynamic and β2-adrenergic receptor-mediated changes that drive the mobilisation of lymphocytes into the bloodstream ([@bib17]). This response is not uniform, with lymphocytes such as CD8^+^ T-cells with high antigen specificity, activation and migratory capacity being preferentially mobilised (e.g. effector T-cells) ([@bib4]). The general consensus is that this response is highly functional, and operates to enhance immunosurveillance and tissue remodelling in the period after exercise ([@bib5]). As a result, exercise immunology research has largely focussed on characterising CD8^+^ T-cells with regards to their activation, migration and effector functions (e.g. cytotoxicity). Conversely, relatively little attention has been paid to negative regulators of T-cell function, which might act to suppress or modulate this functional redistribution of T-cells. The results of the current study demonstrate that both MOD and HIIE evoke an increase in PD-1+ CD8^+^ T-cell concentration into the bloodstream. The magnitude of this response was comparable between trials; however, the phenotypic responses differed, with the concentration of central memory CD8^+^ T-cells expressing PD-1 ([Fig. 1](#fig1){ref-type="fig"}) and the surface expression level (MFI) on these cells increasing after HIIE only ([Fig. 2](#fig2){ref-type="fig"}). Coupled to the finding that CD8^+^ PD-1- central memory T-cells were not significantly elevated after HIIE (*data not shown*), this indicates a specific phenotypic change with regards to PD-1 regulation within the central memory T-cell pool, rather than just changes in T-cell trafficking into the periphery.

PD-1 is a critical regulator of T-cell tolerance, modulating changes in cell activation ([@bib27]), differentiation ([@bib1]) and migration into tissues ([@bib3]). Expression of PD-1 is primarily limited to memory T-cells ([@bib20]) ([Fig. 2](#fig2){ref-type="fig"}), with progressive loss of the PD-1 receptor documented on T-cells with higher effector functions, such as T~EMRA~, which are typically the most sensitive to exercise-induced mobilisation ([@bib4]). Whereas effector memory T-cells circulate between blood and peripheral tissues, central memory T-cells circulate between lymph and blood ([@bib13]), awaiting antigen presentation. We speculate that an increase in CD8^+^ central memory T-cell PD-1 expression after HIIE may be a homeostatic mechanism to limit T-cell receptor activation, differentiation and redistribution of antigen-specific T-cells from the lymphatic system after exercise. This change is directly related to the intensity of exercise, given that the HIIE protocol controlled for both total exercise duration and the energy cost of exercise, compared to MOD.

The only previous study to investigate changes in immune checkpoint expression after exercise reported an increase in the percentage of PD-1+, but not CTLA-4+ CD8^+^ T-cells after maximal cycling exercise ([@bib20]). A compositional increase in PD-1+ CD8^+^ T-cells was not observed in the present study, and as such, suggests that preferential trafficking of PD-1+ CD8^+^ T-cells may only increase in response to maximal cycling exercise. Notably however, the current study subsequently phenotyped CD8^+^ T-cells, as well as determining physiologically relevant changes within the bloodstream in response to exercise. Importantly, the increase in CD8^+^ PD-1+ central memory T-cells composed a very small component of the total exercise-induced lymphocytosis (Pre-Ex: 0.38% to Post-Ex: 0.69%). Our data therefore provide novel insight into changes in PD-1 within T-cells after different intensities of exercise, both with regards to cell phenotype and physiologically relevant changes within the circulation. Both are undoubtedly important in understanding changes in T-cell function and their redistribution after exercise. Future work should take this approach to establish whether a small increase in CD8^+^ PD-1+ central memory T-cells has physiological relevance in governing the immune responses to exercise. For a more complete picture, other immune checkpoints, such as CTLA-4 should be explored in this context.

Another novel finding from the present study was that exercise evoked an increase in the circulating plasma concentration of sPD-L1 and decrease in sPD-1 immediately, and up to 60 ​min post-exercise ([Fig. 3](#fig3){ref-type="fig"}). These responses were not dependent on the intensity of exercise, nor associated with changes in membrane-bound PD-1 expression or circulating PD-1+ cell numbers. The exact cellular origin and functional actions of these soluble immune checkpoints have yet to be fully established. Both sPD-1 (primarily released from T-cells) and sPD-L1 (released from dendritic cells and tissues) ([@bib19]) can be produced through alternate mRNA splicing ([@bib32]) or cleavage of the membrane-bound form directly ([@bib40]). There is some evidence to suggest that sPD-1 and sPD-L1 may act in an antagonistic manner, such that sPD-1 competes and sPD-L1 engages with membrane-bound PD-1 ([@bib19]; [@bib23]). This is supported by studies suggesting that sPD-1 enhances ([@bib39]) and sPD-L1 inhibits ([@bib30]) T-cell activity. From the current study, we can therefore speculate that an increase in sPD-L1 after exercise may form a component of the anti-inflammatory response to exercise, acting to engage and activate membrane-bound PD-1. This is supported by a reduction in sPD-1 concentration and a positive association between post-exercise sPD-L1 and IL-6 ([Fig. 4](#fig4){ref-type="fig"}), a pleiotropic cytokine with a role in anti-inflammatory signalling ([@bib14]). It must be noted that the cellular mechanisms mediating the removal of sPD-1 from the circulation in this short timeframe after exercise is far from clear at present. Further work is needed to fully understand the kinetics of soluble immune checkpoints after exercise and their functional role is regulating communication between immune cells and tissues.Fig. 4Pearson's correlation between Post-Ex IL-6 and sPD-L1 concentrations across both trials (n ​= ​16).Fig. 4

PD-1 and other immune checkpoints have attracted significant attention in biomedical and clinical research because of their profound impact on regulating immune tolerance in diseases associated with immune dysfunction. Immune checkpoint expression is commonly elevated on T-cells isolated from patients with blood and tissue cancers ([@bib26]; [@bib31]; [@bib33]) and conversely reduced on T-cells from patients with various autoimmune diseases ([@bib2]; [@bib18]; [@bib25]; [@bib29]). How an increase in PD-1 expression after acute exercise translates into changes with regular exercise training, particularly in these populations is currently unknown. It is conceivable that exercise-induced upregulation of PD-1 expression could enhance immune tolerance in patients with certain autoimmune diseases; however, more work is needed to investigate the effects of regular exercise on immune checkpoints in a clinical context.

5. Conclusion {#sec5}
=============

The results of the current study have highlighted phenotypic and physiological relevant changes in PD-1+ CD8^+^ T-cells after bouts of MOD and HIIE. PD-1+ CD8^+^ T-cells are mobilised in response to both types of exercise, however, central memory CD8^+^ T-cells expressing PD-1 increased after HIIE only. Despite this being a very small component of the exercise-induced lymphocytosis, PD-1 expression also increased on these cells, highlighting a specific phenotypic response associated with exercise at higher intensities. We have also highlighted for the first time that soluble immune checkpoints are altered in response to exercise, with sPD-L1 and sPD-1 increasing and decreasing up to 60 ​min after exercise respectively. Further work is needed to examine the changes in membrane and soluble immune checkpoints after exercise, and their relevance to regulating health in the context of autoimmunity.
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[^1]: **Legend:** ∗P ​\< ​0.05; NS P ​\> ​0.05.

[^2]: **Legend:** ∗P ​\< ​0.05; NS P ​\> ​0.05.
